News & Updates
DiaSys is particularly pleased to announce the standardization of the SARS-CoV-2 UTAB FS (UTAB = Universal Total AntiBody) assay.
In order to improve sarcoidosis diagnostics significantly, the research and development department of DiaSys develops a modern and robust determination method for ACE.
Medical decisions depend on accurate, informative, and comparable results. This is only possible by establishing a common measurement base. As a result, global metrology institutions such as EURAMET focus on improving the aspect of comparability.
DiaSys warmly invites you to attend the presentation of our immunoassay developer Thomas Masetto on "Challenges in the development of IVD kits for the measurement of sepsis markers: an IVD manufacturer point of view".
DiaSys is pleased to announce the launch of LDH 21 FS, a new assay for determination of Lactate Dehydrogenase (LDH).
Not only has the pandemic been the dominant issue for the last two years, but the recent floods in the Ahr valley (Rhineland-Palatinate) and neighboring areas have lately added another unexpected and life-threatening situation for many people.
DiaSys is pleased to announce the availability of LDL-c direct FS, a new homogenous assay for direct determination of LDL-cholesterol (LDL-C).
The state Rhineland-Palatinate awards the 2021 Innovation Prize in the category “cooperation“ to DiaSys Diagnostic Systems GmbH along with Hochschule Fresenius – University of Applied Sciences, for developing a new procalcitonin (PCT) test using PETIA technology.